Literature DB >> 17594908

Solution structure of ASPP2 N-terminal domain (N-ASPP2) reveals a ubiquitin-like fold.

Henning Tidow1, Antonina Andreeva, Trevor J Rutherford, Alan R Fersht.   

Abstract

Proteins of the ASPP family bind to p53 and regulate p53-mediated apoptosis. Two family members, ASPP1 and ASPP2, have pro-apoptotic functions while iASPP shows anti-apoptotic responses. However, both the mechanism of enhancement/repression of apoptosis and the molecular basis for their different responses remain unknown. To address the role of the N-termini of pro-apoptotic ASPP proteins, we solved the solution structure of N-ASPP2 (1-83) by NMR spectroscopy. The structure of this domain reveals a beta-Grasp ubiquitin-like fold. Our findings suggest a possible role for the N-termini of ASPP proteins in binding to other proteins in the apoptotic response network and thus mediating their selective pro-apoptotic function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17594908     DOI: 10.1016/j.jmb.2007.05.024

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  11 in total

1.  Autophagic activity dictates the cellular response to oncogenic RAS.

Authors:  Yihua Wang; Xiao Dan Wang; Eleonora Lapi; Alexandra Sullivan; Wei Jia; You-Wen He; Indrika Ratnayaka; Shan Zhong; Robert D Goldin; Christoph G Goemans; Aviva M Tolkovsky; Xin Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-30       Impact factor: 11.205

2.  N terminus of ASPP2 binds to Ras and enhances Ras/Raf/MEK/ERK activation to promote oncogene-induced senescence.

Authors:  Zhiping Wang; Yuangang Liu; Maho Takahashi; Kathryn Van Hook; Kerstin M Kampa-Schittenhelm; Brett C Sheppard; Rosalie C Sears; Philip J S Stork; Charles D Lopez
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

3.  ΔN-ASPP2, a novel isoform of the ASPP2 tumor suppressor, promotes cellular survival.

Authors:  Kathryn Van Hook; Zhiping Wang; Dexi Chen; Casey Nold; Zhiyi Zhu; Pavana Anur; Hun-Joo Lee; Zhiyong Yu; Brett Sheppard; Mu-Shui Dai; Rosalie Sears; Paul Spellman; Charles D Lopez
Journal:  Biochem Biophys Res Commun       Date:  2016-12-08       Impact factor: 3.575

4.  Targeted rescue of a destabilized mutant of p53 by an in silico screened drug.

Authors:  Frank M Boeckler; Andreas C Joerger; Gaurav Jaggi; Trevor J Rutherford; Dmitry B Veprintsev; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-23       Impact factor: 11.205

5.  Molecular interactions of ASPP1 and ASPP2 with the p53 protein family and the apoptotic promoters PUMA and Bax.

Authors:  Seema Patel; Roger George; Flavia Autore; Franca Fraternali; John E Ladbury; Penka V Nikolova
Journal:  Nucleic Acids Res       Date:  2008-08-02       Impact factor: 16.971

6.  Highly homologous proteins exert opposite biological activities by using different interaction interfaces.

Authors:  Anat Iosub Amir; Martijn van Rosmalen; Guy Mayer; Mario Lebendiker; Tsafi Danieli; Assaf Friedler
Journal:  Sci Rep       Date:  2015-07-01       Impact factor: 4.379

7.  ASPP2 attenuates triglycerides to protect against hepatocyte injury by reducing autophagy in a cell and mouse model of non-alcoholic fatty liver disease.

Authors:  Fang Xie; Lin Jia; Minghua Lin; Ying Shi; Jiming Yin; Yin Liu; Dexi Chen; Qinghua Meng
Journal:  J Cell Mol Med       Date:  2014-09-25       Impact factor: 5.310

8.  ASPP2 Is a Novel Pan-Ras Nanocluster Scaffold.

Authors:  Itziar M D Posada; Marc Serulla; Yong Zhou; Christina Oetken-Lindholm; Daniel Abankwa; Benoît Lectez
Journal:  PLoS One       Date:  2016-07-20       Impact factor: 3.240

9.  ASPP1 and ASPP2 bind active RAS, potentiate RAS signalling and enhance p53 activity in cancer cells.

Authors:  Y Wang; N Godin-Heymann; X Dan Wang; D Bergamaschi; S Llanos; X Lu
Journal:  Cell Death Differ       Date:  2013-02-08       Impact factor: 15.828

10.  Regulation of ASPP2 interaction with p53 core domain by an intramolecular autoinhibitory mechanism.

Authors:  Shahar Rotem-Bamberger; Chen Katz; Assaf Friedler
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.